Citigroup Inc Ptc Therapeutics, Inc. Call Options Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 10, 2024	BUY	$24.15 - $31.95 $598,920 - $792,360	24,800 New	24,800 $721,000
Q2 2023 Aug 10, 2023	BUY	$40.4 - $59.1 $1.22 Million - $1.78 Million	30,200 Added 101.34%	60,000 $2.44 Million
Q1 2023 May 11, 2023	SELL	$38.16 - $48.86 $816,623 - $1.05 Million	-21,400 Reduced 41.8%	29,800 $1.44 Million
Q4 2022 Feb 09, 2023	BUY	$33.53 - $54.79 $878,486 - $1.44 Million	26,200 Added 104.8%	51,200 $1.95 Million
Q3 2022 Nov 10, 2022	SELL	$41.85 - $53.85 $209,250 - $269,250	-5,000 Reduced 16.67%	25,000 $1.26 Million
Q2 2022 Aug 10, 2022	BUY	$25.6 - $45.23 $768,000 - $1.36 Million	30,000 New	30,000 $1.2 Million

215

79.2M

122K

212K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.69B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.